Latest Articles
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences - The Globe and Mail
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences The Globe and Mail
Published: Aug. 6, 2025, 1:11 p.m.
AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in - GlobeNewswire
AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in GlobeNewswire
Published: Aug. 6, 2025, 1:03 p.m.
CSX Executive Vice President and Chief Commercial Officer to Address Deutsche Bank’s 2025 Transportation Conference - The Globe and Mail
CSX Executive Vice President and Chief Commercial Officer to Address Deutsche Bank’s 2025 Transportation Conference The Globe and Mail
Published: Aug. 6, 2025, 1 p.m.
Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials - Stock Titan
Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials Stock Titan
Published: Aug. 6, 2025, 1 p.m.
7 Dividend Stocks for 2025 — Some Pay Over 8%, Some Just Refuse to Die - The Globe and Mail
7 Dividend Stocks for 2025 — Some Pay Over 8%, Some Just Refuse to Die The Globe and Mail
Published: Aug. 6, 2025, 12:57 p.m.
MyHealthTeam Now Hosts 11 Communities for People Living with Cancer - StreetInsider
MyHealthTeam Now Hosts 11 Communities for People Living with Cancer StreetInsider
Published: Aug. 6, 2025, 12:25 p.m.
Cartherics unveils cleanroom facility for cell therapy manufacturing - Med-Tech Insights
Cartherics unveils cleanroom facility for cell therapy manufacturing Med-Tech Insights
Published: Aug. 6, 2025, 12:25 p.m.
MyHealthTeam Now Hosts 11 Communities for People Living with Cancer - Morningstar
MyHealthTeam Now Hosts 11 Communities for People Living with Cancer Morningstar
Published: Aug. 6, 2025, 12:23 p.m.
First immunotherapy combination for endometrial cancer approved by NICE - Oncology Central
First immunotherapy combination for endometrial cancer approved by NICE Oncology Central
Published: Aug. 6, 2025, 11:18 a.m.
Watching Your Estrogen Levels? 5 Foods You May Want To Avoid or Limit - health.com
Watching Your Estrogen Levels? 5 Foods You May Want To Avoid or Limit health.com
Published: Aug. 6, 2025, 11:13 a.m.
Link copied to clipboard!